September saw the launch of Acumen by Klaire in US.
This means CDRI 08 (SFIs own extract of bacopa monnieri) is now available in all the SFI Pathway brands.
- As "Potters Memory and Focus" under Potter's
- As "Keenmind" under Flordis
- As "Acumen" under Klaire.
By having CDRI 08 available in all 3 pathway brands will allow us to expand into markets with global consistency and synergies or resources and cost savings.
SFI's vision to offer the best in class quality natural health products is brought to life by offering CDRI 08 via the pathway that people prefer for teir natural health needs.